A study looking at developing a new way to report side effects of treatment online from home (eRAPID)

Cancer type:

Bowel (colorectal) cancer
Breast cancer
Kidney cancer
Lung cancer
Ovarian cancer
Vaginal cancer
Vulval cancer
Womb (uterine or endometrial) cancer





This study looked at developing a new way for people to report any side effects of treatment online from home.

All cancer treatments have side effects. The researchers wanted to develop a new way for people to report any side effects they may have. The new way was for people to use their computer at home to go onto a website, fill in an electronic questionnaire and receive information about how to manage the side effect. If the side effect was serious the website was set up to alert a member of the hospital staff and they would contact the person. All the information would be stored in the person’s hospital records so that the hospital staff could see it.

The researchers hoped that this would allow people to manage their side effects better and help doctors get a better picture of the side effects people have. They also hoped it would help people get medical attention for severe side effects when needed.

The first step was to develop the questionnaire for people to use on the website. The researchers asked people who were having treatment at the Bexley Wing, St James’ University Hospital Leeds to complete the questionnaire. They interviewed them afterwards to find out what they thought about it.

The aims of this study included finding out

  • If the questionnaire was understandable
  • How well the questions related to people’s experience
  • How easy it was to complete

Summary of results

The study team found that people could understand most of the questions and that the questions were mostly easy to answer.

This was a pilot study. It recruited 60 people. Everyone completed a questionnaire about side effects they were having from their treatment.

Afterwards a member of the study team interviewed them. They were asked

  • What they liked or didn’t like
  • If they understood the questions
  • How well the questions related to their own experience
  • If they would use other words to describe their side effects
  • How easy it was to answer the questions
  • How they felt about filling in the questionnaire

The team tape recorded their answers so they could listen to them later on.

After 20 people the study team listened to the interviews. They found there were some questions that people found confusing or difficult to understand. They then reworded the questions and asked the next 20 people for their opinion. This listening and adapting process continued until the views of 60 people had been obtained.

The study team concluded that after making these changes they now have a better questionnaire that is easier to understand.

We have based this summary on information from the team who ran the trial. The information they sent us has been reviewed by independent specialists (peer reviewed Open a glossary item) and published in a medical journal. The figures we quote above were provided by the trial team. We have not analysed the data ourselves.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Galina Velikova

Supported by

National Institute for Health Research (NIHR)
NIHR Clinical Research Network: Cancer
The Leeds Teaching Hospitals NHS Trust
University of Leeds

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 8649

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Over 60,000 cancer patients enrolled on clinical trials in the UK last year.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page